Antibacterial molybdenum disulfide with silver phosphate coating on titanium fixator in rabbit models of rib fracture infection.

Background: In rib fractures, infection of the fracture ends can affect the use of the implant, causing surgical failures. Molybdenum disulfide with silver phosphate [MoS(S)-AgPO] coating for titanium plates has bactericidal effects . This study aimed to determine the most optimal MoS(S)-AgPO coating for fracture healing in a novel rabbit rib fracture infection (RFI) model. This study hypothesizes that MoS(S)-AgPO coated titanium implants will reduce bacterial infection and inflammation, while promoting osteogenesis and fracture healing in a rabbit RFI model.

Methods: Twenty rabbits were used to create the RFI model using 0, 1×10, 1×10, and 1×10 colony-forming units (CFU)/mL of culture. Twelve rabbits were used to test titanium (Ti) titanium MoS(S)-AgPO-coated (Ti-MoS-AgPO) (with 808-nm near-infrared light irradiation) fixators on rib fractures with . Tissues were examined using hematoxylin-eosin (HE) and safranin-O staining. Western blotting was performed for interleukin (IL)-6 and tumor necrosis factor (TNF)-α. MoS(S)-AgPO safety was assessed using hemolysis, blood assays, and major organ histology. Antibacterial efficacy was tested using Gram staining and bacterial cultures.

Results: In the negative control (NC) group, the incision healed well, but the 1×10, 1×10, and 1×10 CFU/mL groups showed pus coating and abscesses. IL-6 and TNF-α expression in the infected groups was significantly higher than in the NC group (all P<0.01). Safranin-O staining showed reduced osteogenesis in the infected groups the NC group (all P<0.01). Ti, Ti-MoS, and Ti-MoS-AgPO were biocompatible according to the hemolysis and biochemistry assays and major organ histology. Dense bacterial accumulation was seen in the Ti group, while the Ti-MoS-AgPO group showed sparse bacterial colonies, achieving a 99.43% antibacterial rate.

Conclusion: An RFI model was successfully constructed in rabbits. MoS-AgPO-coated titanium implants appear to be biocompatible and able to manage infection in a rabbit model of RFI.